Vir Biotechnology Appoints Jason O’Byrne as Chief Financial Officer
Go back to Vir Biotechnology Appoints Jason O’Byrne as Chief Financial Officer| (NASDAQ: VIR) | Delayed: 9.21 -0.56 (5.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.77 | 52 Week High | $ | |||
| Open | $9.61 | 52 Week Low | $ | |||
| Day High | $9.71 | P/E | N/A | |||
| Day Low | $9.03 | EPS | $ | |||
| Volume | 1,060,406 | |||||

